• Nachrichtendetail
• 

11.03.2024 12:15:37 - dpa-AFX: *REGENERON PHARMA: FDA APPROVES PRALUENT INJECTION TO TREAT CHILDREN WITH GENETIC FORM OF HIGH CHOLESTEROL

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	1.006,500	26.06.24 19:05:51	+20,500	+2,08%	996,200	1.002,000	997,200	986,000